Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 6/20 | 0.49 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.49 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TLR4 | O00206 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24263086 | 0.87 | HTR2C (0.44) | MTNR1AMTNR1BHTR2CALDH1A1TP53 | |
| SCHEMBL24263217 | 0.86 | HTR2C (0.43) | MTNR1AMTNR1BHTR2CALDH1A1TP53 | |
| SCHEMBL24263245 | 0.84 | ALDH1A1 (0.42) | MTNR1AMTNR1BHTR2CALDH1A1TP53 | |
| SCHEMBL24263220 | 0.84 | MTNR1A (0.54) | MTNR1AMTNR1BHTR2CTP53CA1 | |
| SCHEMBL24263210 | 0.83 | MTNR1A (0.47) | MTNR1AMTNR1BHTR2CALDH1A1HPGD | |
| SCHEMBL24263083 | 0.82 | NPC1 (0.46) | HTR2CALDH1A1HPGD | |
| SCHEMBL24263130 | 0.81 | MEN1 (0.48) | HTR2CALDH1A1TP53CA1CA2 | |
| SCHEMBL24263096 | 0.81 | ALDH1A1 (0.40) | MTNR1AMTNR1BHTR2CALDH1A1TP53 | |
| SCHEMBL24263133 | 0.81 | NPC1 (0.45) | MTNR1AMTNR1BHTR2CALDH1A1HPGD | |
| SCHEMBL24263099 | 0.81 | HDAC8 (0.41) | MTNR1AMTNR1BHTR2CALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022040508-A1 | COMPOUNDS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS BY TARGETING HLA-DQ2 | IMMUNOMOLECULAR THERAPEUTICS, INC. (US) | 2022-02-24 | — | — | WO | disclosed |